T使,

M Tommy Gambles1, Isaac Kendell2, Jiahui Li1

  • 1Center for Controlled Chemical Delivery, University of Utah, Salt Lake City, UT 84112, USA; Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT 84112, USA.

概括

多抗原T细胞混合剂 (MATCH) 是一种新的分裂抗体免疫疗法,可以改善癌细胞清除,同时减少细胞因子的释放. 这种方法为治疗B细胞恶性瘤提供了更高的安全性和有效性.